CNS drug delivery in stroke: improving therapeutic translation from the bench to the bedside
PT Ronaldson, EI Williams, RD Betterton, JA Stanton… - Stroke, 2024 - Am Heart Assoc
Drug development for ischemic stroke is challenging as evidenced by the paucity of
therapeutics that have advanced beyond a phase III trial. There are many reasons for this …
therapeutics that have advanced beyond a phase III trial. There are many reasons for this …
Stimuli-Responsive Hydrogels for Tissue Engineering and Drug Delivery Applications
RA Kepekçi - Functional Biomaterials, 2023 - taylorfrancis.com
Hydrogels have gained priority among other biomaterials owing to their outstanding
characteristics like biocompatibility, functionality and elasticity. Stimuli-responsive hydrogels …
characteristics like biocompatibility, functionality and elasticity. Stimuli-responsive hydrogels …
CNS Drug Delivery in Stroke: Organic Anion Transporting Polypeptide (OATP)-Mediated Delivery of Atorvastatin Is a Requirement for Neuroprotection
EI Williams - 2024 - search.proquest.com
Stroke is the 5 th most common cause of death and the leading cause of long-term disability
in the United States. Drug development for ischemic stroke is challenging as evidenced by …
in the United States. Drug development for ischemic stroke is challenging as evidenced by …